MedPath

AMBULATORY OXIMETRY MONITORING (AOM): a New Approach to Quantify Oxygen Desaturation in Ambulatory COPD Patients

Conditions
Pulmonary Disease, Chronic Obstructive
Registration Number
NCT01873092
Lead Sponsor
VA New York Harbor Healthcare System
Brief Summary

Chronic obstructive lung disease (COPD) is characterized by airflow obstruction that is progressive over many years and is largely irreversible. Advanced COPD is associated with arterial oxygen desaturation leading to a series of complications and, ultimately, decreased survival. Long-term oxygen therapy can improve clinical outcomes in these patients, but the exact target of oxygen saturation that actually translates into improvements is not known. The basis for the work in this proposal is to focus a new approach to measure oxygen desaturation linked to daily activity. Accelerometers are used to measure daily activity and then synchronized with ambulatory oximetry to establish an activity/oxygen-saturation profile for individual patients. The three main objectives of this study are 1) determine the feasibility of AOM as a measurement of the temporal profile of oxygen saturation in patients with chronic lung disease; 2) determine if serial AOM-derived data is reliable and reproducible; and 3) determine thresholds of oxygen desaturation that are associated with different activity profiles

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. Veteran patients with a diagnosis of COPD or other chronic lung disease
  2. able to read and understand English
  3. > 45 years old
  4. ambulatory and able to perform functional testing
Exclusion Criteria
  1. unable or unwilling to give informed consent
  2. daily use of a motorized cart
  3. impairment of cognition or communication
  4. history of drug or alcohol treatment within the past 6 months
  5. poor peripheral blood flow to the finger rendering oxygen saturation by pulse oximetry unreliable
  6. Recent acute medical events (chest pain, discomfort, etc) that would suggest a contraindication to participate at the scheduled time

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ambulatory oximetry/activity profileData is collected over 30-34 consecutive hours

Oxygen saturation is measured with a pulse oximeter that has the capacity to collect data over 30- 34 hours; physical activity is measured with two pizo-electric accelerometers. Oximetry and activity data are synchronized to define a profile of oxygen saturation that is linked to usual daily activity.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

VA, New York Harbor Healthcare Service

🇺🇸

Brooklyn, New York, United States

© Copyright 2025. All Rights Reserved by MedPath